Request Deal Involvement
YS Biopharma to go public via a SPAC merge with Summit Healthcare Acquisition in an $834m deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Ogier
legal advisors
Cooley
legal advisors
Jingtian & Gongcheng
legal advisors
Maples Group
legal advisors
Wilson Sonsini Goodrich & Rosati
or
Principals
bidder
SUMMIT HEALTHCARE ACQUISITION CORP
target
YS BIOPHARMA
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite